Neonatally-induced diabetes: Lipid profile outcomes and oxidative stress status in adult rats;Diabete induzido no período neonatal: Repercussões no perfil lipídico e avaliação dos marcadores de estresse oxidativo na vida adulta de ratas

Revista da Associacao Medica Brasileira

Volumn 55, Issue 4, 2009, Pages 384-388

  Sinzato, Yuri Karen ^a   Lima, Paula Helena Ortiz ^a   de Campos, Kleber Eduardo ^a   Kiss, Ana Carolina Inhasz ^a   Rudge, Marilza Vieira Cunha ^a   Damascene, Débora Cristina ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Diabetes; Experimental study; Lipid; Oxidative stress; Rat streptozocin

Indexed keywords

EID: 70450162792     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302009000400010     Document Type: Article

References (40)

1. Rolo AP, Palmeira CM. Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 2006;212(2):167-78.
2. Baynes J. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40(4):405-12.
3. Vincent AM, Brownlee M, Russell JW. Oxidative stress and programmed cell death in diabetic neuropathy. Ann N Y Acad Sci. 2002;959:368-83.
4. Therond P, Bennefont-Rousselot D, Davit-Spraul A, Conti M, Legrand A. Biomarkers of oxidative stress: an analytical approach. Currt Op Clin Nutr Metab Care. 2000;3(5):373-84.
5. Droge W. Aging-related changes in the thiol/disulfide redox state: implications for the use of thiol antioxidants. Exp Gerontol. 2002;37(12):1333-45.
6. Damasceno DC, Volpato GT, Calderon IMP, Rudge MVC. Oxidative stress and diabetes in pregnant rats. Anim Reprod Sci. 2002;72(3-4):235-44.
7. Tavridou A, Unwin NC, Laker MF, White M, Alberti GK. Serum concentrations of vitamin A and E in impaired glucose tolerance. Clin Chim Acta. 1997;266(2):129-40.
8. Calderon IMP, Rudge MVC, Brasil MAM, Henry MACA. Diabete e gravidez experimental em ratas I. Indução do diabete, obtenção e evolução da prenhez. Acta Cir Bras. 1992;7(1):142-6.
9. Sinzato YK, Damasceno DC, Lima PHO, Souza MSS, Amorin RL, Calderon IMP, et al. Effect of maternal smoke exposure in the placental morphometry and maternal-fetal DNA damage. Placenta. 2006;27(Suppl 1):A59.
10. Damasceno DC, Volpato GT, Calderon IMP, Aguilar R, Rudge MVC. Effect of Bauhinia forficata extract in diabetic pregnant rats: maternal repercussions. Phytomedicine. 2004;11(2-3):196-201.
11. Nash P, Eriksson UJ. Suramin-restricted blood volume in the placenta of normal and diabetic rats is normalized by vitamin E treatment. Placenta. 2007;28(5-6):505-15.
12. Portha B, Levacher C, Picon L, Rosselin G. Diabetogenic effect of streptozotocinin on the rat during the perinatal period. Diabetes. 1974;23(11):888-95.
13. Portha B, Picon L, Rosselin G. Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia. 1979;17(6):371-7.
14. Portha B, Kergoat M. Dynamics of glucose-induced insulin release during the spontaneous remission of streptozotocin diabetes induced in the newborn rat. Diabetes. 1985;34(6):574-9.
15. Bonner-Weir S, Trent DF, Honey RN, Weir GC. Responses of neonatal rat islets to streptozotocin. Limited B-cell regeneration and hyperglycemia. Diabetes. 1981;30(1):64-9.
16. Wang RN, Bouwens L, Kloppel G. Beta-cell growth in adolescent and adult rats treated with streptozotocin during the neonatal period. Diabetologia. 1996;39(5):548-57.
17. Murali B, Goyal RK. Improvement in insulin sensitivity by losartan in non-insulin-dependent diabetic (NIDDM) rats. Pharmacol Res. 1999;44(5):385-9.
18. Ulicná O, Zlatos L, Holzerová J, Kvaszová E, Cársky J, Gvozdjáková A, et al. The effect of streptozotocin-induced diabetes in the neonatal period on hepatic mitochondrial bioenergetics in adult rats. Bratisl Lek Listy. 1999;100(1):5-11.
19. Shafrir E, Desoye G. Pregnancy in diabetic animals. In: Hod M, Jovanovic L, Di Renzo GC, Leiva A, Langer O. Textbook of diabetes and pregnancy. United Kingdon: Informa UK Ltd.; 2003. p. 96-7.
20. Ferreira ALA, Machado PEA, Matsubara LS. Lipid peroxidation, antioxidant enzymes and glutathione levels in human erythrocytes exposed to colloidal iron hydroxide in vitro. Braz J Med Biol Res. 1999;32(6):689-94.
21. Young DS. Effects of drugs on clinical laboratory tests. London: AACC Press; 2000.
22. Zar JH. Bioestatistical analysis. New Jersey: Prentice Hall; 1999.
23. Movassati J, Saulnier C, Portha B. Insulin administration enhances growth of the β-cell mass in streptozotocin-treated newborn rats. Diabetes. 1997;46:1445-52.
24. Fantus IG, Chayoth R, O'Dea L, Marliss E, Yale J-F, Grose M. Insulin binding and glucose transport in adipocytes in neonatal streptozotocin-injected rat model of Diabetes mellitus. Diabetes. 1987;36(5):654-660.
25. Blondel O, Bailbé D, Portha B. Insulin resistance in rats with non-insulin-dependent diabetes induced by neonatal (5 days) streptozotocin: evidence for reversal following phorizin treatment. Metabolism. 1990;39(8):787-93.
26. Weir GC, Leahy JL, Bonner-Weir S. Experimental reduction of b-cell mass. Implications for the pathogenesis of diabetes. Diabetes Metab Rev. 1986;2(1-2):125-61.
27. Raman M, Nesto RW. Heart disease in Diabetes mellitus. Chronic complications in diabetes. Endocrinol Metab Clin North Am. 1996;25(2):425-38.
28. Feher MD, Ekelles RS. Editorial: Lipid modification and coronary heart disease in type 2 diabetes: different from the general population? Heart. 1999;81(1):10-11.
29. American Diabetes Association. Dyslipidemia management in adults with diabetes. Diabetes Care. 2004;27(Suppl 1):S68-71.
30. Ribeiro EB, Marmo MR, Andrade IS, Dolninkoff MS. Effect of fasting on monosodium glutamate-obese rats. Braz J Med Biol Res. 1989;22(7):919-21.
31. nd ed. Washington (DC): National Institutes of Health; 1995. p. 117-64.
32. Syvänne M, Taskinen MR. Lipids and lipoproteins as coronary risk factors in non-insulin-dependent Diabetes mellitus. Lancet. 1997;350(Suppl I):20-3.
33. Howard BV, Ruotolo G, Robbins DC. Obesity and dyslipidemia. Endocrinol Metab Clin. 2003;32(4):855-67.
34. Damaso AR. Obesidade e regulação endócrina da ingestão alimentar. In: Obesidade. Rio de Janeiro: Medsi; 2003. p.54-63.
35. Horowitz BS, Goldberg IJ, Merab J, Vanni T, Ramakrishnan R, Ginsberg HN. Increased plasma and renal clearance of an exchangeable pool of apolipo-protein A-I in subjects with low levels of high density lipoprotein cholesterol. J Clin Invest. 1993;91:1743-60.
36. Muruganandan S, Gupta S, Kataria M, Lal J, Gupta PK. Mangiferin protects the streptozotocin-induced oxidative damage to cardiac and renal tissues in rats. Toxicology. 2002;176(3):165-73.
37. Tormo MA, Romero de Tejada A, Morales I, Paredes S, Sánchez S, Barriga C, et al. Orally administered tryptophan and experimental type 2 diabetes. Mol Cell Biochem. 2004;261(1-2):57-61.
38. Sailaja Devi MM, Suresh Y, Das UN. Preservation of the antioxidant status in chemically-induced Diabetes mellitus by melatonin. J Pineal Res. 2000;29(2):108-15.
39. Seghrouchni I, Drai J, Bannier E, Riviere J, Calmard P, García I, et al. Oxidative stress parameters in type I, type II and insulin-treated type 2 Diabetes mellitus: insulin treatment efficiency. Clin Chim Acta. 2002;321(1-2):89-96.
40. Mak DH, Ip SP, Li PC, Poon MK, Ko KM. Alterations in tissue glutathione antioxidant system in streptozotocin-induced diabetic rats. Mol Cell Biochem. 1996;162 (2):153-8.